“a decreasing trend”

A decreasing trend on the change from inappropriate treatments to appropriate ones was observed: 3.5 vs. 1.5; p = 0.12.

Incidence among males aged 15–19 years shifted in 2010 from an increasing trend (APC from 2006 to 2010 = 27.0; P = 0.12) to a decreasing trend (APC from 2010 to 2014 = −14.3; P = 0.25), although neither segment was significant ( Table 2 , Fig. 1 ).

A decreasing trend (not significant) for working memory errors (50%; p = 0.12) was evident in Ts65Dn treated with InRapa (Fig. 2f ) compared to Ts65Dn Veh.

Applicants with non-PhD graduate degrees had decreased probabilities of matching (p<0.01), and applicants with PhD degrees had no statistically significant change in match probability from the average applicant though a decreasing trend was noted (p=0.12).

As shown in Figure 6 , the expression of ɑ-SMA ( P < 0.05) was significantly increased, whereas that of integrin β1 showed a decreasing trend ( P = 0.12) in L-IOP eyes compared to control eyes.

3.2 Vaccination 3.2.1 Pediatric vaccinations Immunization activities experienced a decreasing trend with nonseasonal activities (QS test P = 0.12 and kwman test P = 0.09), and appear to be non-stationary (augmented Dickey–Fuller test P = 0.5).

Our results demonstrated that treatment with cabergoline decreased 2-h insulin level (P = 0.02), and showed a decreasing trend in fasting insulin level (P = 0.12) ( 29 ).

The salivary cortisol measures demonstrated a decreasing trend without statistical significance (0.131 to 0.118, P = .12).

In addition, both antipsychotic groups showed a decreasing trend in DGsp and had no effects in DGip ( F (2, 12)= 2.543, P= .120; Figure 3G , H ).

While the presence of PSS remained unaltered (71%) at the 9‐month time‐point in MF‐Sed mice, it showed a decreasing trend in MF‐Ex mice (PSS 40%, P =0.12, McNemar test) (Figure 5 ).

Oxidized-LDL showed a decreasing trend at 4 weeks (p = 0.123).

For persons 20–64 years of age, VE point estimates showed a decreasing trend (77.1%in the first phase and 41.0% in the second; p = 0.124); however, the CIs were wide.

The CASA program demonstrated a decreasing trend (pre: 6, post: 2, 77% reduction, P = 0.125).

Per-reader analysis showed that CBIR software use of reader 1 slightly increased from session B (6/14, 42.9%) to D (7/14, 50%), whereas software use of reader 2 showed a decreasing trend (12/14, 85.7% versus 8/14, 57.1%, p = 0.125).

5 ) and a decreasing trend from 2020 to 2023 (APC = −38.1%, 95% CI: −70.0% to 27.9%, P = 0.1260, Table 5 ; Fig. 5 ), neither of which was statistically significant.

Myrcene concentration at 0.5 h (774.8 ± 64.0 μg/L) increased significantly compared with baseline ( p = 0.012), reached its peak at 2 h (905.6 ± 44.6 μg/L) and followed a decreasing trend until 24 h, when its concentration (648.2 ± 60.3 μg/L) was not significantly increased compared with baseline ( p = 0.128).

The amount of proteinuria showed a decreasing trend at 6 months since RIT (3.0 ± 2.2 g/g, versus that at the time of RIT, P = 0.129) compared to the value at the time of RIT; this trend was observed even at the last followup (2.9 ± 2.7 g/g, versus at the time of RIT, P = 0.136). 3.3.

There was a decreasing trend in G1F from Process A (15.8 ± 1.4%) to B (12.6 ± 4.8%, p = .13 compared to Process A) to C (5.7 ± 0.6%, p < .0001 compared to Process A, p < .01 compared to Process B).

Lung weight showed a decreasing trend in the DOXO-only group compared to the control group ( p = 0.13).

With regard to the cost, a decreasing trend was observed (− 8%, p = 0.1300).

Between 8th to 10th decile subgroups, there was a decreasing trend of urine outputs in the higher IL-6 decile groups ( P = 0.13, minimum IL-6 level of 8th decile group is 1434.8 pg/mL) (Fig. 3 b).

Additionally, the ΔE1 parameter, reflecting color differences, revealed a decreasing trend in the cheek area for the GEN + group, with a statistically significant difference observed with PP analysis (ITT: MD = –0.39, 95% CI: –0.89 to 0.12, p = 0.13; PP: MD = –0.56, 95% CI: –1.06 to –0.06, p = 0.03), suggesting improved color consistency (Figure 2 ).

In overall, there was a decreasing trend towards loss of non-reference alleles or mutant alleles in the corresponding tumour samples (P = 0.13, t = 1.53) ( Fig 2 ).

At baseline, the proportion of naive T cells was significantly reduced in nonresponders compared with HCs ( p = 3.4e–05, Figure 2J ), but only showed a decreasing trend in responders ( p = 0.13).

There was a decreasing trend in the use of third-generation cephalosporins (AUD, 292.7 ± 39.9 vs. 256.2 ± 27.6, p = 0.132) and vancomycin (AUD, 360.6 ± 25.9 vs. 310.8 ± 48.6, p = 0.078) between the two means, however, the difference was not statistically significant ( Fig. 2 ).